The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial

Mark Nimmer*, Jason Czachor, Laura Turner, Bobbe Thomas, Ashley L. Woodford, Karli Carpenter, Victor Gonzalez, Robert I. Liem, Angela Ellison, T. Charles Casper, David C. Brousseau, for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN)

*Corresponding author for this work

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these challenges. Overall, 48 patients were enrolled after being preconsented. Variable Institutional Review Board policies related to preconsent validity and its allowable duration decreased the advantages of preconsent at some sites. The utility of preconsent for future intervention trials largely depends on local Institutional Review Board policies. Preeducation may also benefit the consent process, regardless of site differences.

Original languageEnglish (US)
Pages (from-to)1649-1652
Number of pages4
JournalPediatric Blood and Cancer
Volume63
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Research Ethics Committees
Legal Guardians
Pediatrics
Emergency Medicine
Hematology
Education

Keywords

  • consent
  • preconsent, pediatric hematology/oncology
  • sickle cell disease

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Nimmer, M., Czachor, J., Turner, L., Thomas, B., Woodford, A. L., Carpenter, K., ... for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN) (2016). The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial. Pediatric Blood and Cancer, 63(9), 1649-1652. https://doi.org/10.1002/pbc.26013
Nimmer, Mark ; Czachor, Jason ; Turner, Laura ; Thomas, Bobbe ; Woodford, Ashley L. ; Carpenter, Karli ; Gonzalez, Victor ; Liem, Robert I. ; Ellison, Angela ; Casper, T. Charles ; Brousseau, David C. ; for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN). / The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial. In: Pediatric Blood and Cancer. 2016 ; Vol. 63, No. 9. pp. 1649-1652.
@article{d99b16b29bbb47cf8afd5948383b3d3a,
title = "The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial",
abstract = "Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these challenges. Overall, 48 patients were enrolled after being preconsented. Variable Institutional Review Board policies related to preconsent validity and its allowable duration decreased the advantages of preconsent at some sites. The utility of preconsent for future intervention trials largely depends on local Institutional Review Board policies. Preeducation may also benefit the consent process, regardless of site differences.",
keywords = "consent, preconsent, pediatric hematology/oncology, sickle cell disease",
author = "Mark Nimmer and Jason Czachor and Laura Turner and Bobbe Thomas and Woodford, {Ashley L.} and Karli Carpenter and Victor Gonzalez and Liem, {Robert I.} and Angela Ellison and Casper, {T. Charles} and Brousseau, {David C.} and {for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN)}",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/pbc.26013",
language = "English (US)",
volume = "63",
pages = "1649--1652",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "9",

}

Nimmer, M, Czachor, J, Turner, L, Thomas, B, Woodford, AL, Carpenter, K, Gonzalez, V, Liem, RI, Ellison, A, Casper, TC, Brousseau, DC & for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN) 2016, 'The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial', Pediatric Blood and Cancer, vol. 63, no. 9, pp. 1649-1652. https://doi.org/10.1002/pbc.26013

The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial. / Nimmer, Mark; Czachor, Jason; Turner, Laura; Thomas, Bobbe; Woodford, Ashley L.; Carpenter, Karli; Gonzalez, Victor; Liem, Robert I.; Ellison, Angela; Casper, T. Charles; Brousseau, David C.; for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN).

In: Pediatric Blood and Cancer, Vol. 63, No. 9, 01.09.2016, p. 1649-1652.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial

AU - Nimmer, Mark

AU - Czachor, Jason

AU - Turner, Laura

AU - Thomas, Bobbe

AU - Woodford, Ashley L.

AU - Carpenter, Karli

AU - Gonzalez, Victor

AU - Liem, Robert I.

AU - Ellison, Angela

AU - Casper, T. Charles

AU - Brousseau, David C.

AU - for the sickle cell working group of the Pediatric Emergency Care Applied Research Network (PECARN)

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these challenges. Overall, 48 patients were enrolled after being preconsented. Variable Institutional Review Board policies related to preconsent validity and its allowable duration decreased the advantages of preconsent at some sites. The utility of preconsent for future intervention trials largely depends on local Institutional Review Board policies. Preeducation may also benefit the consent process, regardless of site differences.

AB - Enrollment of patients in sickle cell intervention trials has been challenging due to difficulty in obtaining consent from a legal guardian and lack of collaboration between emergency medicine and hematology. We utilized education and preconsent in a pediatric multisite sickle cell intervention trial to overcome these challenges. Overall, 48 patients were enrolled after being preconsented. Variable Institutional Review Board policies related to preconsent validity and its allowable duration decreased the advantages of preconsent at some sites. The utility of preconsent for future intervention trials largely depends on local Institutional Review Board policies. Preeducation may also benefit the consent process, regardless of site differences.

KW - consent

KW - preconsent, pediatric hematology/oncology

KW - sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84978775512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978775512&partnerID=8YFLogxK

U2 - 10.1002/pbc.26013

DO - 10.1002/pbc.26013

M3 - Article

C2 - 27081930

AN - SCOPUS:84978775512

VL - 63

SP - 1649

EP - 1652

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 9

ER -

Nimmer M, Czachor J, Turner L, Thomas B, Woodford AL, Carpenter K et al. The Benefits and Challenges of Preconsent in a Multisite, Pediatric Sickle Cell Intervention Trial. Pediatric Blood and Cancer. 2016 Sep 1;63(9):1649-1652. https://doi.org/10.1002/pbc.26013